News

Janssen Research & Development, LLC announced it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) to update the prescribing information for XARELTO® (rivaroxaban) to add a 10 mg dose...

CardioComm Solutions, Inc., a consistent, global medical provider of consumer heart monitoring and medical electrocardiogram software solutions, announced it has entered into a development, distribution and co-marketing agreement with...

Acutus Medical®, a company committed to transforming the lives of millions of patients with complex arrhythmias, announced that enrollment has been completed in its pivotal Utilizing Novel Dipole Density Capabilities to Objectively Visualize...

ARCA biopharma, Inc., a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, announced that the 200th patient has been randomized into the GENETIC-AF...

AtriCure, Inc., a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage management, announced it has sold more than 100,000 AtriClip® Left Atrial Appendage Exclusion System devices worldwide, which...

SpringBoard Healthcare, a leading provider of advanced staffing and education solutions, announced that Providence Health and Services recently selected them to provide electrophysiology (EP) education for approximately 200 lab employees. By...

After nearly a decade of research and development, BIOTRONIK announced the launch of Plexa ProMRI®, the smallest (7.8F) MR conditional tachycardia lead available in the United States. The US Food and Drug Administration (FDA) approved Plexa...

Physio-Control announced that the company’s HeartSine® samaritan® PAD 360P (SAM 360P) fully automatic external defibrillator (AED) is now available for sale in the United States, having received U.S. Food and Drug Administration (FDA)...

Cardiac Insight, a U.S. developer of body worn sensing devices and computational software, announced the FDA has cleared the company’s wearable electrocardiogram (ECG) sensor, CARDEA SOLO™. The device offers physicians immediate access to...

Boston Scientific has initiated a worldwide study that will evaluate the survival benefit of patients treated with the EMBLEM™ MRI Subcutaneous Implantable Defibrillator (S-ICD) System who are aged 65 and older with a history of prior heart...